» Articles » PMID: 33445826

Associations of Depression and Anxiety with Cardiovascular Risk Among People Living with HIV/AIDS in Korea

Overview
Specialty Public Health
Date 2021 Jan 15
PMID 33445826
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: As HIV/AIDS is becoming a chronic disease, the risk of developing cardiovascular disease (CVD) among people living with HIV/AIDS is rising. Anxiety and depression, which are common among people living with HIV/AIDS, have been linked with CVD. This study investigated the risk of CVD in people living with HIV/AIDS and explored the effects of depression and anxiety on CVD risk.

Methods: Data were collected for 457 people enrolled in the Korea Cohort HIV/AIDS study after 2010. Framingham risk scores were calculated to quantify the 10-year risk of developing CVD. Depression and anxiety variables were re-coded as a single combined variable. Multivariable logistic regression analysis was performed, adjusting for age, body mass index, low-density lipoprotein (LDL) cholesterol, triglycerides (TG), duration of human immunodeficiency virus (HIV) positivity after entry into the cohort, and depression/anxiety.

Results: Participants with both depression and anxiety were 2.28 times more likely than those with neither depression nor anxiety to have moderate/high-risk CVD risk. The 10-year risk of developing CVD was affected by LDL cholesterol, TG, age, and duration of HIV infection. LDL cholesterol and TG levels change according to the duration of HIV infection, and metabolic disorders affect the risk of CVD. Thus, a longer duration of HIV infection is associated with a higher risk of developing CVD.

Conclusions: Screenings for depression and anxiety need to be provided regularly to assess the severity of those symptoms. To help decrease their risk of developing CVD, people living with HIV/AIDS should be offered behavioral modification interventions aimed at developing healthy lifestyle habits.

Citing Articles

Depressive Symptoms and Left Ventricular Diastolic Dysfunction Among Men and Women with HIV.

Martinez C, Haw N, Rodriguez V, Kizer J, Post W, Wu K Eur Med J Cardiol. 2025; 12(1):106-120.

PMID: 39936004 PMC: 11812528. DOI: 10.33590/emjcardiol/AKTG4946.


Elevated frequency and everyday functioning implications of vascular depression in persons with HIV disease.

Beltran-Najera I, Mustafa A, Warren D, Salling Z, Misiura M, Woods S J Psychiatr Res. 2023; 160:78-85.

PMID: 36780803 PMC: 10123762. DOI: 10.1016/j.jpsychires.2023.02.003.

References
1.
Shimizu S, Chow D, Valcour V, Masaki K, Nakamoto B, Kallianpur K . The Impact of Depressive Symptoms on Neuropsychological Performance Tests in HIV-Infected Individuals: A Study of the Hawaii Aging with HIV Cohort. World J AIDS. 2012; 1(4):139-145. PMC: 3467015. DOI: 10.4236/wja.2011.14020. View

2.
Whooley M, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney R . Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008; 300(20):2379-88. PMC: 2677371. DOI: 10.1001/jama.2008.711. View

3.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

4.
Kim E, Hwang S . [Development and evaluation of a small group-based cardiocerebrovascular disease prevention education program for male bus drivers]. J Korean Acad Nurs. 2012; 42(3):322-32. DOI: 10.4040/jkan.2012.42.3.322. View

5.
Rozanski A . Optimism and other sources of psychological well-being: a new target for cardiac disease prevention. Circ Heart Fail. 2014; 7(3):385-7. DOI: 10.1161/CIRCHEARTFAILURE.114.001303. View